2013
DOI: 10.6061/clinics/2013(02)oa14
|View full text |Cite
|
Sign up to set email alerts
|

Female sexual dysfunction in patients with substance-related disorders

Abstract: OBJECTIVE:To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit.METHODS:This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence Data questionnaire, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0
7

Year Published

2013
2013
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 30 publications
(27 citation statements)
references
References 29 publications
(53 reference statements)
2
18
0
7
Order By: Relevance
“…Where papers drew clients from two modalities, they were coded to whichever category represented more than half of the patients involved in the paper . Two papers reporting cocaine as the primary drug treated were grouped in the ‘alcohol and other drug’ category .…”
Section: Methodsmentioning
confidence: 99%
“…Where papers drew clients from two modalities, they were coded to whichever category represented more than half of the patients involved in the paper . Two papers reporting cocaine as the primary drug treated were grouped in the ‘alcohol and other drug’ category .…”
Section: Methodsmentioning
confidence: 99%
“…Sexual dysfunction significantly affects a woman's quality of life and self-esteem [4]. Several risk factors to the development of female sexual dysfunction have been identified in the literature, including postmenopausal status, long-term relationship with the partner, diabetes, pregnancy, alcohol consumption, nicotine use, pelvic organ prolapse (POP) and urinary incontinence (UI) [5][6][7][8]. Treatment of any aetiological factor may improve a woman's sexual function (SF).…”
Section: Introductionmentioning
confidence: 99%
“…The severity scale has been used in several studies, and measures of reliability and validity have been reported to be satisfactory in all the versions for utilization as a clinical and/or research tools (Yudko, Lozhkina & Fouts, 2007). In the latter study, the Cronbach's alpha of DAST was 0.92, which indicates excellent internal consistency (Diehl, Silva, & Laranjeira, 2013).…”
Section: Drug Abuse Screening Test (Dast-20) the Drug Abusementioning
confidence: 61%
“…We acknowledge that the selection of the DAST might represent another limitation in the present study. However, it is worth emphasizing that the Cronbach's alpha of this tool was 0.92 in a previous study conducted by our group (Diehl et al, 2013), which indicates excellent internal consistency. Additionally, in the present study, none of the scales data were represented as continuous variables.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation